Obbligazioni societarie HIGH YIELD e oltre, verso frontiere inesplorate - Vol. 1

Stato
Chiusa ad ulteriori risposte.
Io francamente non so che fare anche perche' ho seguito poco e sarei tentato di non fare nulla o vendere la posizione per evitare casini.

Il tempo scade e bisogna decidere nel mio caso entro il 19. Tra parentesi bisogna mandare una lettera negli USA.

L’eventuale adesione dovrà essere inviata a [email protected] entro, e non oltre, il 19.04.2017 ore 10:00 allegando il modulo di adesione debitamente compilato. Contestualmente all’invio dell’adesione via mail all’ufficio corporate action, gli obbligazionisti dovranno scaricare dal seguente sito Eligibility l’ Eligibility Letter, compilarla ed inoltrarla via posta a

To the attn. of Corporate Actions
c/o Global Bondholder Services Corporation
65 Broadway - suite 404, New York,
New York 10006,

QUALCUNO DEL FORUM SAPREBBE CONSIGLIARE CHE FARE?

GRAZIE E BUONA PASQUA A TUTTI.
Intelsat SA plans to extend today’s bond exchange deadline for at least a few more days and will almost certainly need to raise the offers. Creditors made a proposal after the deal was announced in February, asking to be paid out near par. Intelsat in February proposed a debt exchange as part of the satellite provider’s plan to merge with OneWeb, which is backed by SoftBank Group. The swap, which gives bondholders an average of 74 cents on the dollar, would ease Intelsat’s struggle with more than $15 billion of debt after two leveraged buyouts. The OneWeb merger is contingent on completing the exchange. Some of the notes are trading at prices meaningfully above what the company initially proposed. SoftBank will invest $1.7 billion in cash and hold a 39.9% voting stake in the combined company. The Intelsat-OneWeb merger agreement requires a minimum amount of interest coverage for debt at the new entity.
 
UNILAB HOLDINGS 5.75 nuova emissione

_ Geneva headquartered pan-European clinical laboratory services and medical diagnostic imaging services network

_ Shareholders: 93.2% Apax (private equity fund), 6.6% Management

_ acquisition of Alpha Medical, market leader in Slovakia and Czech Republic, financed with both debt and new equity

_ 6 countries representing 84% revenues (Switzerland 24%, France 22%, Sweden 17% and Norway, Czech and Slovakia each 7%)

_ healthcare budgets under pressure, economies of scale increasingly important for cost efficiencies

_ market leading (top 4) in 8 of 14 geographies

_ management change in 2013, since then positive organic EBITDA growth (2014-2016: +17%)

_ 50% contracted revenues

_ net debt / EBITDA 6.6x

_ Unilabs Holding ratings: B stable by S&P and B3 positive by Moody’s

_ issue ratings CCC+ / Caa2 due to structural subordination

sto tentando oggi di prenderlo in emissione ma non so se ci sono riuscito.
 
Stato
Chiusa ad ulteriori risposte.

Users who are viewing this thread

Back
Alto